KLOW Quad-Peptide Blend

KLOW is a four-part research blend that pairs three skin- and repair-related peptides with KPV, a tiny peptide studied for calming inflammation.

It's studied in skin research — whether dampening inflammation alongside repair signals improves skin-matrix rebuilding in lab models.

Skin-injury models showed reduced inflammation signals and faster skin-cell migration. No human benefit is established.

Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.

KLOW is an unapproved research blend. It is not for human therapeutic or cosmetic use.

BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.

Laboratory research reagent only.

• In-vitro cytokine downregulation and matrix gene activation under quad-peptide formulation.

Specific citations are provided for literature context. Product purity & lot verification documentation available on request.